Founded in 2000, Landing Med is a medtech company focused on early cancer detection solutions. We offer affordable and accessible AI-powered cytology & digital pathology technologies to empower laboratories worldwide to enhance diagnostic precision, efficiency, and confidence. As a globally recognized leader in cervical cytology screening, we have successfully screened over 10 million women and strive to make pathology accessible to all.
Landing Med provides an end-to-end solution with AI-powered cervical cytology, optimizing lab efficiency and reducing review times. With over 10 million cases screened, it’s ideal for large-scale cancer screening programs.
Landing Med offers cost-effective scanner solutions tailored to both small clinics and large labs. Whether you’re handling just a few slides per day or several hundred, our scanners are designed to digitize glass slides efficiently, providing scalable support for labs of any size.
LBC Solutions offers a comprehensive range of Liquid Based Cytology Consumables, including Cell Preservation Solution, Papanicolaou Stain, Cleaning Liquid, and Production Booth. Additionally, we provide Disposable Cervical Brushes, Coverslips, Neutral Balsam, and Oscillators. Our Slide Preparation Machine ensures efficient and accurate cytology slide preparation.
Singapore – March 21, 2025 – Landing Med, a global leader in AI-driven cervical cytology screening, has been awarded first prize for its scientific abstract “Artificial Intelligence Cytological Scr...
Landing Med was named a 2024 Top Innovative Healthcare Company by Forbes China, recognizing its groundbreaking AI-powered cervical cancer screening solutions. Its scalable technology has enhanced screening access for 11+ million women, particularly in underserved areas.
Seoul, South Korea – October 2-4, 2024Landing Med’s Chief Technology Officer (CTO), Dr. Pang Baochuan, was invited to speak at the inaugural Asia Society of Digital Pathology Congress in Seoul, Sout...